"Chart & Float" Today's Top summary picks: Chart

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone
868
"Chart & Float"
Today's Top [ 42 ] summary picks:

Chart Plays $0.0002 To $12.30

2014789399_stockshares.jpg

**Rules and regs below after the stocks.

...................................................

$BTX upturn $2.70
AMEX
Website float 125.58 M
100% x 100% strong buy
filings and news



..................................................

$TXHD at resistance $0.3899
OTC
Website ultra low float 3.73 M
40% x 100% buy
filings and news


taxtmunication.png
..................................................

$LXRP recovery flag $2.05
OTC
former bottom play winner
Website low float 54.20 M
60% x 100% strong buy
filings and news


Lexaria_Bioscience_Logo_Dark_WEB.png
..................................................

$LTRX pull back $5.50
Nasdaq CM
former bottom play winner
Website ultra low float 7.30 M
50% x 100% buy
filings and news


logo-lantronix@2x.png
..................................................

$LDSR bottom bounce $0.011
OTC
former bottom play winner
Website float 2.8 B
67% sell x 40% buy
filings and news


Subsidiary
Data443_Horizontal.jpg
..................................................

$HIPH at resistance $0.02
OTC
former bottom play winner
Website O/S 130,341,925
% hold
filings and news



..................................................

$GRYN Candle breakout $0.27
OTC
former bottom play winner
Website ultra low float 4.70 M
100% x 100% strong buy
filings and news


170-gryn-logo.png
..................................................

$FFRMF at resistance $0.40
OTC former bottom play winner float 117.08 M
Website
33% x 60% buy
filings and news


FuterFarmsTech_logo2.png
..................................................

$GRWG at resistance $5.15
OTC
former bottom play winner
Website ultra low float 19.67 M
33% x 80% buy
filings and news


gglogo_withtag-colored.png
..................................................

$DNR breakout $5.20
NYSE former bottom play winner
Website float 434.04 M
80% x 100% strong buy
filings and news


logo.png
..................................................

$GEN upturn $1.40
NYSE former bottom play winner
Website low float 44.73 M
67% sell x 40% buy
filings and news


genesislogo.png
..................................................

$AWX upturn $4.48
AMEX former bottom play winner
Website ultra low float 2.13 M
25% 67% buy
filmings and news


office.gif
..................................................

$ISIG at breakout $2.25
Nasdaq CM
Website
33% x 100% buy
filings and news


new-isi-logo-with-tm-120-1.png
..................................................

$KRKNF upturn $0.326
OTC
Website low float 76 M
67% x 100% strong buy
filings and news


kraken-logo.png
..................................................

$FFRMF at resistance $0.42
OTC
Website float 117.08 M
33% x 80% buy
filings and news


FuterFarmsTech_logo2.png
..................................................

$CTSO at breakout $12.30
Nasdaq CM
Website ultra low low float 25-84 M
40% buy x 75% buy
filings and news


logo.jpg
...................................................

$IMUN at resistance(bottom) $0.20
OTC
Website float 346.9 M
20% sell x 67% sell
filings and news


WEBSITE_LOGO_single_color-e1461268103818.png
..................................................

$MRGE higher lows $0.0185
OTC
Website float 119 M
67% sell x 60% buy
filings and news


logo-dark.png
..................................................

$GNMK at breakout $7.70
Nasdaq GM
Website low float 51.41 M
80% x 100% strong buy
filings and news


logo.jpg
..................................................

$KBLB at resistance $0.065
OTC
Website float 587 M
25% x 80% buy
filings and news



..................................................

$AVMXY up channel $1.43
OTCQX an ol' fav
Website O/S 673,219,854
100% x 100% strong buy
filings and news


logo_res_new.png
.................................................

$AMS at breakout resistance $3.10
Amex
Website ultra low float 3.57 M
80% x 100% strong buy
filings and news 08/13/2018
< Resumption of Proton Therapy Services at Orlando Health 08/13/2018
< Second Quarter 2018 08/09/2018


logo1.jpg
.................................................

$IVST at resistance $0.2933
OTC
Website ultra low float 17.8 M
33% x 60% buy
filings and news


..................................................

$RIBT at resistance $3.00
Nasdaq CM
Website ultra low float 14.6 M
80% x 100% strong buy
filings and news



.................................................

$REPR at resistance #1 $1.40
OTCQX
Website ultra low float 18.74 M
hold x 100% buy
filings and news



..................................................

$ELTP at resistance PRs $0.1159
OTC
Website
100% x 100% strong buy
filings and news
< FDA Approval for Generic Methadone 08/06/2018
< FDA Approval for Generic Percocet® 07/03/2018




.................................................

$ABIO ascending triangle $0.59
Nasdaq GM
Website ultra low float 13.75 M
hold x 40% buy
filings and news



..................................................

NVTA breakout $8.80
NYSE
Website low float 62.18 M
100% x 100% strong buy
filings and news



.................................................
$UATG at support $0.0011
OTC
Website float 162.4 M
25% x 60% buy
filings and news


uat-public-logo.png
..................................................

$KCAP ascending triangle $3.20
Nasdaq GS
Website low float 34.39 M
67% x 100% strong buy
filings and news

logo.png

...................................................

$DNAD at resistance $0.0037
OTC
Website float 166.3 M
67% sell x 20% buy
filings and news



..................................................

$USAT gaps and candles $10.00
Nasdaq CM
Website low float 47.69 M
100% x 100% strong buy
filings and news


usa-technologies-logo.png
..................................................

$TRXC at resistance $3.75
AMEX
Website float 151 M
75% x 100% strong buy
filings and news


..................................................

$ARQL candle $6.00
Nasdaq GM
called 3/17/18 $1.95
Website low float 79.53
100% x 100% buy
filings and news 4/17/18
World License Agreement

ArQule-Inc..jpg
...................................................

$BIEL Triple 0 staging
$0.0009/$0.0012
OTC
Website O/S shares 18.08 B
25% x 67% buy
filings and news


BioElectronics-Logo-with-tagline-1-e1462835964289.png
...................................................

$WTER time to call it $0.90
OTC
multiple bottom / increasing revenues
Website ultra low float 19.62 M
20% sell x 67% buy
filings and news



..................................................

$HAON Pr bot $0.0002
OTC
Website float 6.73 B
hold x 33% buy
filings and news 2/28/18
Q-10 #4 revenues


mV2ZXbTA_400x400.jpg
...................................................

$FUSZ looking for support $0.50
OTC Bot .33 / sold half $2.40
Website float 104 M
hold x 80% sell
filings and news


nFusz-Black-SMALL.png
..................................................

$ADTM exclusive to MJ financing
$0.0005 OTC
(N/A)Website float 172.43 M
60% sell x 75% buy
filings and news 1/12/19 Restructures
Into Pure Play Cannabis Company


New logo and website coming.

...................................................

$ONCI bottom call
OTC $0.0009
Website float 346M
33% x 100% sell
filings and news



..................................................

$USRM bottom call $0.02
OTC
Website float 327M
50% sell x 67% buy
Filings and news

ussc-logo-web1.jpg
..................................................

$ZYXI bottom call $2.50
bot .68 / $3.40
5-bagger
OTC Website
ultra low float 19.35M
Barchart Opinion
filings and news
Revenues 5/8/18
Waiting on game changing FDA:
Volume Heart Monitor

zynex-medical-logo.png
.................................................

** Riles and regulations:

Note:
We are adopting a policy
of barring and deleting paid humps and the like !!
I will delete any paid promo. They come here to make
some use of our casual stock sharing environment.
Good riddance.

Sign in the entrance window:



We will also delete any so-called market research
advertisement or any post fronting such off-site and
any off-site email sign-up or company solicitation.

< All foreign exchange stocks are welcome so long
as their exchange is clearly shown each posting.


TBCContest Make a bottom - support call.

689005935_tbcciBox.jpg

A word to the wise:
"Stock picking is work".
"The stock market
is all about work."

"Just you and it "


1256418079_theride.jpg

We follow stocks with a low float < 100M
and stocks with an ultra low float < 30M.
But whatever is moving well, makes a1list.

Charts qualify that are looking up in some way:
on a moving average at resistance or support,
or with a staging formation such as a bull flag.
An upgrading Pr is great too.

The float shown is the highest number
from OTCMarkets-YahooFinance-WSJournal.
I use the highest of any two I look at.
Re: O/S Checked against SEC filings.

Barchart daily regardless of float:
Top 1% inc 100% x 100% strong buys.

Big Time Triple 000 Board
A friend at iHub.
Trader53: "At certain times
it is worth it to take a "Trip".
Triple 000 iBox.
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 15

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading

Top 5 Most Recently Viewed Articles

ANI Pharmaceuticals Plans to Shine at Biotech Conference

Updated Category News Views 257

ANI Pharmaceuticals Set for Key Presentation at Biotech Conference ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is gearing up to showcase its advancements at the Guggenheim Biotech Conference. On an exciting date, Nikhil Lalwani, the Company’s President and CEO, along with Stephen Carey, the CFO, will host a fireside chat to discuss the latest developments and future plans...

Continue Reading
New Shuttle Drives Economic Recovery on O'ahu

Updated Category News Views 26

Reviving the North Shore Economy, One Shuttle Ride at a Time Not every day do you see a $5 investment with such community punch. On June 29, a new bus service launches, whisking folks from Waik?k? and Ko Olina to O?ahu’s North Shore. But this ain't just another tourist bus ride—it's a lifeline for local businesses hit hard by March's kona low storms. Connecting...

Continue Reading
Virginia Cancer Specialists Expands Services with New Center

Updated Category News Views 21

Virginia Cancer Specialists Expands its Reach with a New Center Virginia Cancer Specialists, a leading private cancer practice in the region, has announced the opening of their newly expanded cancer center. This important development aims to enhance patient care and provide access to the latest cancer treatments. The expansion not only signifies growth but also a...

Continue Reading
Key Financial Dates for TCM Group A/S's Upcoming Year

Updated Category News Views 167

Important Financial Calendar for TCM Group A/S TCM Group A/S is a significant player in the kitchen and furniture manufacturing industry. As the year approaches its end, the company has established key dates for reporting and annual meetings, signaling to shareholders and stakeholders the importance of staying informed. Scheduled Report Releases and Meetings The Board of...

Continue Reading
Unexpected Chicago PMI Falls Raises Concerns for Manufacturing

Updated Category News Views 323

Understanding the Recent Chicago PMI Decline Recently, the Chicago Purchasing Managers' Index (PMI) reported a surprising score of 36.9, highlighting ongoing challenges in the manufacturing sector within the region. This score is a clear indication that the manufacturing landscape in Chicago is experiencing significant contraction, a worrisome sign for the local and...

Continue Reading